@article{1440552,
      recid = {1440552},
      author = {Hashimoto, Kenji, and Manto, Mario,},
      title = {New rapid-acting antidepressants /},
      publisher = {Springer,},
      address = {Cham, Switzerland :},
      pages = {1 online resource},
      year = {2021},
      note = {Includes index.},
      abstract = {This book discusses new candidates for rapid-acting  antidepressants, such as (R)-ketamine,  (2R,6R)-hydroxynorketamine, scopolamine, mGluR2/3  antagonists and AMPA receptor agonists. There are serious  limitations to currently available antidepressants, such as  delayed onset and low rates of efficacy. The discovery that  a single dose of ketamine, an NMDAR antagonist, can produce  rapid antidepressant effects that are sustained has led to  new research in this area. In this volume, a variety of  novel pharmaceutical treatments are examined. This volume  would be useful to both researchers and clinicians who work  in the field of pharmacology, specifically CNS drug  treatments. Discusses new candidate for rapid-acting  antidepressants Provides information for those who work in  the field of CNS drugs Ideal for pharmacologists,  psychiatrists, and those who want to learn about CNS drugs  at the graduate level.},
      url = {http://library.usi.edu/record/1440552},
      doi = {https://doi.org/10.1007/978-3-030-79790-4},
}